Ariad Pharmaceuticals Inc (ARIA) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
26 LANDSDOWNE ST CAMBRIDGE, MA 02139 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 352,688 | 237,179 | 164,414 | |||
| Cash and cash equivalents | 352,688 | 237,179 | 119,379 | |||
| Short-term investments | 45,035 | |||||
| Receivables | 8,397 | 1,305 | 101 | |||
| Inventory, net of allowances, customer advances and progress billings | 979 | 419 | 6 | |||
| Inventory | 979 | 419 | 6 | |||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | 3,835 | ||
| Other current assets | 23,578 | 6,043 | ✕ | |||
| Other undisclosed current assets | (6) | |||||
| Total current assets: | 385,642 | 244,946 | 168,350 | |||
| Noncurrent Assets | ||||||
| Inventory, Noncurrent | 460 | 2,985 | ||||
| Property, plant and equipment | 203,027 | 108,777 | 7,681 | |||
| Intangible assets, net (including goodwill) | 939 | 968 | 993 | |||
| Intangible assets, net (excluding goodwill) | 939 | 968 | 993 | |||
| Restricted cash and investments | 11,308 | 11,357 | 1,038 | |||
| Other undisclosed noncurrent assets | 2,494 | 1,861 | 2,131 | |||
| Total noncurrent assets: | 218,228 | 125,948 | 11,843 | |||
| TOTAL ASSETS: | 603,870 | 370,894 | 180,193 | |||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities | 45,872 | 40,881 | 34,193 | |||
| Employee-related liabilities | 21,095 | 12,778 | 11,865 | |||
| Accounts payable | 10,819 | 11,363 | 8,267 | |||
| Accrued liabilities | 13,958 | 16,740 | 14,061 | |||
| Debt | 4,200 | 2,115 | ||||
| Deferred compensation liability | 2,511 | 3,533 | ||||
| Deferred revenue and credits | 17,100 | 1,800 | 231 | |||
| Customer advances and deposits | 17,308 | ✕ | ✕ | |||
| Other liabilities | 17,830 | 15,136 | 698 | |||
| Other undisclosed current liabilities | (8,112) | 7,649 | 8,096 | |||
| Total current liabilities: | 89,998 | 72,177 | 48,866 | |||
| Noncurrent Liabilities | ||||||
| Long-term debt and lease obligation | 156,908 | 4,900 | 9,100 | |||
| Long-term debt, excluding current maturities | 156,908 | 4,900 | 9,100 | |||
| Liabilities, other than long-term debt | 91,543 | 10,888 | 11,576 | |||
| Deferred revenue and credits | 75,505 | 308 | 538 | |||
| Accounts payable and accrued liabilities | 4,700 | |||||
| Deferred compensation liability, classified | 1,968 | |||||
| Liability for uncertainty in income taxes | 2,000 | 2,200 | ||||
| Other liabilities | 11,338 | 8,580 | 6,870 | |||
| Other undisclosed noncurrent liabilities | ||||||
| Total noncurrent liabilities: | 248,451 | 15,788 | 20,676 | |||
| Total liabilities: | 338,449 | 87,965 | 69,542 | |||
| Equity | ||||||
| Equity, attributable to parent | 80,801 | 185,517 | 112,851 | |||
| Common stock | 187 | 186 | 167 | |||
| Additional paid in capital | 1,299,394 | 1,238,859 | 890,499 | |||
| Accumulated other comprehensive income (loss) | (4,185) | (1,535) | 20 | |||
| Accumulated deficit | (1,214,595) | (1,051,993) | (777,835) | |||
| Total equity: | 80,801 | 185,517 | 112,851 | |||
| Other undisclosed liabilities and equity | 184,620 | 97,412 | (2,200) | |||
| TOTAL LIABILITIES AND EQUITY: | 603,870 | 370,894 | 180,193 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|
| Revenues | 105,412 | 45,561 | 558 | ||
| Revenue, net | 55,720 | 45,238 | |||
| Cost of revenue (Cost of Goods and Services Sold) | (5,224) | (17,212) | (145) | ||
| Gross profit: | 100,188 | 28,349 | 413 | ||
| Operating expenses | (265,607) | (319,127) | (205,618) | ||
| Other undisclosed operating income | 5,224 | 17,212 | 145 | ||
| Operating loss: | (160,195) | (273,566) | (205,060) | ||
| Nonoperating expense | (1,777) | (153) | (15,812) | ||
| Investment income, nonoperating | 85 | 130 | (15,684) | ||
| Gain (loss), foreign currency transaction, before tax | 1,445 | (130) | 71 | ||
| Interest and debt expense | (8,075) | (153) | (199) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 8,075 | 153 | |||
| Loss from continuing operations before income taxes: | (161,972) | (273,719) | (221,071) | ||
| Income tax expense (benefit) | (630) | (439) | |||
| Loss from continuing operations: | (162,602) | (274,158) | (221,071) | ||
| Loss before gain (loss) on sale of properties: | (162,602) | (274,158) | (221,071) | ||
| Net loss: | (162,602) | (274,158) | (221,071) | ||
| Other undisclosed net income attributable to parent | 199 | ||||
| Net loss available to common stockholders, diluted: | (162,602) | (274,158) | (220,872) | ||
Comprehensive Income ($ in thousands)
| 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|
| Net loss: | (162,602) | (274,158) | (221,071) | ||
| Other comprehensive income (loss) | (2,650) | (1,555) | 20 | ||
| Comprehensive loss: | (165,252) | (275,713) | (221,051) | ||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 199 | ||||
| Comprehensive loss, net of tax, attributable to parent: | (165,252) | (275,713) | (220,852) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.